Predicting the outcome of non-pharmacological treatment for patients with dementia-related mild cognitive impairment.

ABSTRACT: Dementia is a progressive cognitive syndrome, with few effective pharmacological treatments that can slow its progress. Hence, non-pharmacological treatments (NPTs) play an important role in improving patient symptoms and quality of life. Designing the optimal personalised NPT strategy relies on objectively and quantitatively predicting the treatment outcome. Magnetoencephalography (MEG) findings can reflect the cognitive status of patients with dementia, and thus potentially predict NPT outcome. In the present study, 16 participants with cognitive impairment underwent NPT for several months. Their cognitive performance was evaluated based on the Mini-Mental State Examination and the Alzheimer's Disease Assessment Scale - Cognitive at the beginning and end of the NPT period, while resting-

SUBMITTER: Shigihara Y 

PROVIDER: S-EPMC7762505 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature